Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svrcek

Showing results (231-240 of 299) with videos related to

Pageof 30
Sort By:
Molecular Oncology|December 26, 2021
Immune microenvironment in patients with mismatch-repair-proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort studyMarine Jary, Wen-Wei Liu, Dongyao Yan, et al.
Pancreas|September 11, 2015
Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With Pancreatic AdenocarcinomaJean-Baptiste Bachet, Fabien Gay, Raphaël Maréchal, et al.
Oncogene|June 3, 2016
The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease developmentA-L Joly, A Deepti, A Seignez, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 12, 2019
High IGF1R protein expression correlates with disease-free survival of patients with stage III colon cancerAziz Zaanan, Claire Calmel, Julie Henriques, et al.
British Journal of Cancer|November 8, 2013
Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic studyT Aparicio, M Svrcek, A Zaanan, et al.
Free Radical Research|March 13, 2025
SOD mimics delivered to the gut using lactic acid bacteria mitigate the colitis symptoms in a mouse model of inflammatory bowel diseasesGabrielle Schanne, Amandine Vincent, Florian Chain, et al.
Oncogenesis|September 20, 2018
Targeting nonsense-mediated mRNA decay in colorectal cancers with microsatellite instabilityA'dem Bokhari, Vincent Jonchere, Anaïs Lagrange, et al.
Cellular and Molecular Life Sciences : CMLS|September 26, 2012
Extensive characterization of sphere models established from colorectal cancer cell linesAda Collura, Laetitia Marisa, Diletta Trojan, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 29, 2025
FOLFIRINOX or FOLFOX for locally advanced or metastatic small bowel adenocarcinoma: PRODIGE 86 - FFCD-GONO - ENGIC 02 - FOLFIRINOX SBA phase II randomized trialThomas Aparicio, Anthony Turpin, Aziz Zaanan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 21, 2023
Multicenter Harmonization Study of Pan-Trk Immunohistochemistry for the Detection of NTRK3 FusionsJulien Adam, Nolwenn Le Stang, Arnaud Uguen, et al.
Pageof 30

Showing results (231-240 of 299) with videos related to

Sort By:
Pageof 30
Molecular Oncology|December 26, 2021
Immune microenvironment in patients with mismatch-repair-proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort studyMarine Jary, Wen-Wei Liu, Dongyao Yan, et al.
Pancreas|September 11, 2015
Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With Pancreatic AdenocarcinomaJean-Baptiste Bachet, Fabien Gay, Raphaël Maréchal, et al.
Oncogene|June 3, 2016
The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease developmentA-L Joly, A Deepti, A Seignez, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 12, 2019
High IGF1R protein expression correlates with disease-free survival of patients with stage III colon cancerAziz Zaanan, Claire Calmel, Julie Henriques, et al.
British Journal of Cancer|November 8, 2013
Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic studyT Aparicio, M Svrcek, A Zaanan, et al.
Free Radical Research|March 13, 2025
SOD mimics delivered to the gut using lactic acid bacteria mitigate the colitis symptoms in a mouse model of inflammatory bowel diseasesGabrielle Schanne, Amandine Vincent, Florian Chain, et al.
Oncogenesis|September 20, 2018
Targeting nonsense-mediated mRNA decay in colorectal cancers with microsatellite instabilityA'dem Bokhari, Vincent Jonchere, Anaïs Lagrange, et al.
Cellular and Molecular Life Sciences : CMLS|September 26, 2012
Extensive characterization of sphere models established from colorectal cancer cell linesAda Collura, Laetitia Marisa, Diletta Trojan, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 29, 2025
FOLFIRINOX or FOLFOX for locally advanced or metastatic small bowel adenocarcinoma: PRODIGE 86 - FFCD-GONO - ENGIC 02 - FOLFIRINOX SBA phase II randomized trialThomas Aparicio, Anthony Turpin, Aziz Zaanan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 21, 2023
Multicenter Harmonization Study of Pan-Trk Immunohistochemistry for the Detection of NTRK3 FusionsJulien Adam, Nolwenn Le Stang, Arnaud Uguen, et al.
Pageof 30